225 related articles for article (PubMed ID: 27704370)
1. Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ.
Manders JB; Kuerer HM; Smith BD; McCluskey C; Farrar WB; Frazier TG; Li L; Leonard CE; Carter DL; Chawla S; Medeiros LE; Guenther JM; Castellini LE; Buchholz DJ; Mamounas EP; Wapnir IL; Horst KC; Chagpar A; Evans SB; Riker AI; Vali FS; Solin LJ; Jablon L; Recht A; Sharma R; Lu R; Sing AP; Hwang ES; White J;
Ann Surg Oncol; 2017 Mar; 24(3):660-668. PubMed ID: 27704370
[TBL] [Abstract][Full Text] [Related]
2. The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ result.
Alvarado M; Carter DL; Guenther JM; Hagans J; Lei RY; Leonard CE; Manders J; Sing AP; Broder MS; Cherepanov D; Chang E; Eagan M; Hsiao W; Schultz MJ
J Surg Oncol; 2015 Jun; 111(8):935-40. PubMed ID: 26031501
[TBL] [Abstract][Full Text] [Related]
3. DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS.
Rakovitch E; Parpia S; Koch A; Grimard L; Soliman H; Stevens C; Perera F; Kong I; Senthelal S; Anthes M; Wiebe E; Cao J; Goldberg M; Smith S; Spadafora L; Whelan TJ
Breast Cancer Res Treat; 2021 Jul; 188(1):133-139. PubMed ID: 33830392
[TBL] [Abstract][Full Text] [Related]
4. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
[TBL] [Abstract][Full Text] [Related]
5. Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery.
Punglia RS; Jiang W; Lipsitz SR; Hughes ME; Schnitt SJ; Hassett MJ; Nekhlyudov L; Achacoso N; Edge S; Javid SH; Niland JC; Theriault RL; Wong YN; Habel LA
Breast Cancer Res Treat; 2018 Feb; 167(3):751-759. PubMed ID: 29079937
[TBL] [Abstract][Full Text] [Related]
6. Evaluating patterns of utilization of gene signature panels and impact on treatment patterns in patients with ductal carcinoma in situ of the breast.
Bhutiani N; Vuong B; Egger ME; Eldredge-Hindy H; McMasters KM; Ajkay N
Surgery; 2019 Oct; 166(4):509-514. PubMed ID: 31337506
[TBL] [Abstract][Full Text] [Related]
7. The impact of publication of Australian treatment recommendations for DCIS on clinical practice: A population-based, "before-after" study.
White V; Pruden M; Kitchen P; Villanueva E; Erbas B
Eur J Surg Oncol; 2010 Oct; 36(10):949-56. PubMed ID: 20724103
[TBL] [Abstract][Full Text] [Related]
8. Genomic Assays in Ductal Carcinoma In Situ: Implications for Management Decisions.
Gangi A; Topham A; Lee MC; Sun W; Laronga C
South Med J; 2017 Oct; 110(10):649-653. PubMed ID: 28973706
[TBL] [Abstract][Full Text] [Related]
9. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.
Lalani N; Paszat L; Sutradhar R; Thiruchelvam D; Nofech-Mozes S; Hanna W; Slodkowska E; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Chang MC; Jani PA; Bonin M; Rakovitch E
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1017-24. PubMed ID: 25220719
[TBL] [Abstract][Full Text] [Related]
11. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
[TBL] [Abstract][Full Text] [Related]
12. Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ.
Shumway DA; McLeod CM; Morrow M; Li Y; Kurian AW; Sabolch A; Hamilton AS; Ward KC; Katz SJ; Hawley ST; Jagsi R
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1237-1245. PubMed ID: 29439886
[TBL] [Abstract][Full Text] [Related]
13. Radiation Therapy Following Breast Conserving Surgery for Ductal Carcinoma in situ: Yes or No?
Stoleru LS; Stoleru S
Chirurgia (Bucur); 2017; 112(4):403-412. PubMed ID: 28862116
[TBL] [Abstract][Full Text] [Related]
14. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
[TBL] [Abstract][Full Text] [Related]
15. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Rakovitch E; Nofech-Mozes S; Hanna W; Baehner FL; Saskin R; Butler SM; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Robertson SJ; Slodkowska E; Fong C; Anderson JM; Jamshidian F; Miller DP; Cherbavaz DB; Shak S; Paszat L
Breast Cancer Res Treat; 2015 Jul; 152(2):389-98. PubMed ID: 26119102
[TBL] [Abstract][Full Text] [Related]
16. American Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation.
DeSnyder SM; Hunt KK; Dong W; Smith BD; Moran MS; Chavez-MacGregor M; Shen Y; Kuerer HM; Lucci A
Ann Surg Oncol; 2018 Oct; 25(10):2965-2974. PubMed ID: 29987598
[TBL] [Abstract][Full Text] [Related]
17. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of low-risk ductal carcinoma in situ in Southeast Asian women treated with breast conservation therapy.
Wong FY; Wang F; Chen JJ; Tan CH; Tan PH
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):998-1003. PubMed ID: 24661651
[TBL] [Abstract][Full Text] [Related]
19. Selective use of whole breast radiotherapy after breast conserving surgery for invasive breast cancer and DCIS.
Skandarajah AR; Bruce Mann G
Surgeon; 2013 Oct; 11(5):278-85. PubMed ID: 23632044
[TBL] [Abstract][Full Text] [Related]
20. The current clinical value of the DCIS Score.
Wood WC; Alvarado M; Buchholz DJ; Hyams D; Hwang S; Manders J; Park C; Solin LJ; White J; Willey S
Oncology (Williston Park); 2014 May; 28 Suppl 2():C2, 1-8, C3. PubMed ID: 25375000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]